Marked decrease. Profit-taking sell-off is occurring in reaction to the sharp rise the previous day. Some media reported that there has been a rush of buying due to the evaluation of technology that efficiently synthesizes compounds that target proteins related to the cause and treatment effects of diseases, not only by major domestic companies like Eisai <4523>, but also by mega-pharmas extending their partnership. However, today it seems that selling is leading as it was pushed back near the 25-day moving average line.
ＰＲＩＳＭＢｉｏ---大幅に反落、前日急騰の反動で利益確定売り、「エーザイなど提携の手伸ばす」と報道
PRISM Bio fell sharply, profit-taking sell-off after the previous day's sharp rise, reported to be reaching out for partnerships with Eisai etc.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.